2010

Tobacco and trade marks seminar

IPRIA is hosting a seminar on the Commonwealth Government’s announced intention to ban the use of artwork and logos on cigarette packaging.

Speakers:

  • Prof. Mark Davison
  • Prof. John Freebairn, a professor of economics at Melbourne Uni
  • Ass. Prof. Angela Paladino, who teaches in Marketing at Melbourne Uni (and is a recipient of over $2M in competitive funding)
  • Tim Wilson, the Director of Intellectual Property and Free Trade unit at the Institute of Public Affairs.

They threaten to “consider the economic, legal, ethical and marketing implications of this decision”. Unfortunately, there is no indication that Kev10 will be there to perform his patented double pike with backflip. However, it does seem that the Senate Committee inquiring into the bill is not due to report until 26 August 2010. (although submissions should well and truly be in by now).

Where:

Wednesday, 26 May 2010 at 6pm (Lecture Theatre GO8, Melbourne Law School)

The seminar is free and there are CPD points going.

Details and registration here.

Tobacco and trade marks seminar Read More »

Inventive step standard

Tom Cordiner (from the Victorian Bar and a registered patent attorney) and Beth Webster (from IPRIA) are giving a seminar for IPRIA and IPTA on Raising the Inventive Step: A Look at the Issues:

Brisbane on 18 May 2010

Sydney on 19 May 2010

Melbourne on 21 May 2010

The seminars are free and if you are subject to the continuing education requirements of the Professional Standards Board, the Queensland, Victorian or NSW Bars or the Law Society of NSW garner you one “point”.

Details and registration via here.

Inventive step standard Read More »

The grace period and “reasonable trial”

Mack Innovations lodged a provision patent application for a “cable pulling apparatus for helicopters” on 12 August 2005. The complete application for a standard patent was lodged on 14 August 2006 and a standard patent was subsequently granted (yes, 12 and 13 August 2006 fell on the weekend).

Apparently, Mack Innovations had begun testing parts and subsequently a prototype of the device in public around March 2005; i.e., about 5 months before the provisional application was lodged.

Rotorco, having been sued for infringement, tried to argue that  Mack Innovations’ own actions in March 2005 had rendered the patent “not novel”; contending that the grace period did not apply because the complete application was filed more than 12 months after first public use.

The problem for Rotorco was that its summary judgment application was based on reg. 2.2(2)(d), not 2.2(1A). Reg. 2.2(1A) provides for a grace period where there was a publication or use “within 12 months before the filing date of the complete application”. On the other hand, reg. 2.2(2)(d) applies where:

(d)    the working in public of the invention within the period of 12 months before the priority date of a claim for the invention:
(i)    for the purposes of reasonable trial; and
(ii)    if, because of the nature of the invention, it is reasonably necessary for the working to be in public.

and Tamberlin J, albeit in dicta, had already ruled that filing the provisional application on which the patent was based within the 12 months grace period was sufficient for reliance on this provision.

One might add that, given the difference in wording between reg. 2.2(1A) and 2.2.(2)(d), this conclusion seems consistent with the Full Court’s decision in Mont Adventure Equipment (admittedly dealing with the application of the grace period in the context of a divisional application).

Mack Innovations (Australia) Pty Limited & Anor v Rotorco Pty Limited & Anor [2010] QSC 138 (McMurdo J)

As this was an application for summary judgment, I am not sure whether that means it still remains to be resolved whether or not Mack Innovations’ use was in fact reasonable trial which it was reasonably necessary to conduct in public.

The grace period and “reasonable trial” Read More »

Does the international intellectual property system help or hinder exporters?

Is the question that will be addressed at a 3 hour forum in Melbourne on 25 May 2010, organised by IP Australia.

Three speakers:

Amy Roy, General Counsel of Boost Juice.
Amy will discuss the Boost Juice experience in regards to exporting and protecting their IP overseas. She will also discuss what can be improved from a business perspective to make the IP system easier for exporters to use.

Karen Sinclair, President of the Licensing Executives Society of Australia and New Zealand.
Karen will discuss how the IP system affects the role of an attorney, what works well, what does not work well and the future outlook.

Victor Portelli, General Manager of Patents and Plant Breeder’s Rights at IP Australia.
Victor will discuss the current international IP systems in place, trends in the international environment and possible future developments.

Registration is free and includes lunch.

Details and rsvp here.

Does the international intellectual property system help or hinder exporters? Read More »

Not complying with an injunction

IP disputes often involve the (alleged) infringer providing undertakings or being subjected to injunctions to stop infringing the IP in the future. The sanction for non-compliance being (potentially) contempt of court.

The long running Deckers litigation has now reached the point where Tracey J has found a number of the respondents in contempt of court for breaching undertakings and injunctions from litigation in 2003, 2004 and 2007.

His Honour’s reasons provide a useful guide to prove the contempt(s). Unfortunately, it looks like there will need to be another hearing to establish the penalty.

Deckers Outdoor Corporation Pty Ltd v Farley (No 6) [2010] FCA 391

Not complying with an injunction Read More »

Draft ACTA text released

Draft ACTA text released Read More »

TRIPs protocol: Australian implementation consultation

IP Australia has issued a consultation paper on implementing the TRIPS protocol.

The TRIPS protocol is the modification (or is that clarification?) of TRIPS obligations to improve the availability of “crisis” pharmaceuticals in least developed and developing countries. From the discussion paper:

The TRIPS Protocol seeks to address this problem by amending the TRIPS Agreement to permit WTO members to issue compulsory licences to produce patented pharmaceutical products for export to least-developed and developing countries. The main features of the Protocol are:
• Licences may only be issued for products of the pharmaceutical sector needed to address public health concerns.
• Countries eligible to import pharmaceuticals under the system comprise any least-developed WTO country or any other WTO country that has notified the TRIPS Council.
• Importing countries are obliged to provide the TRIPS Council with details such as the names and quantities of the products needed and whether they need to issue a compulsory licence in their own country.
• Exporting countries are obliged to notify the TRIPS Council of a range of details and ensure that importing countries have done the same.
• Both importers and exporters must have in place anti-diversion measures to ensure the products produced under the system reach the intended market and are not re-exported.

Read the paper here (pdf).

Submissions due by 4 June 2010.

TRIPs protocol: Australian implementation consultation Read More »

Plant breeder’s rights in the EU

The European Court of Justice has dismissed Ralf Schräder’s appeal from the rejection of its registration for plant breeder’s rights in plectranthus ornatus.

It would seem after detailed genetic testing, including travel to South Africa, the EU regulatory authorities have determined the variety the subject of the application is not distinct from a common South African plant.

IPKat has a good overview, with links to earlier stages in the dispute, here.

Case C?38/09 P Ralf Schräder v Community Plant Variety Office

Plant breeder’s rights in the EU Read More »

High Court allows appeal in Health World

The High Court has unanimously allowed Health World’s appeal from the Federal Court’s ruling that it was not an “aggrieved person” and so had no standing to seek rectification of Shin Sun’s HEALTHPLUS trade mark.

Shin Sun had registered HEALTH PLUS for pharmaceutical products including vitamins and dietary supplements in class 5; and Health World was using INNER HEALTH PLUS for the same type of goods and had successfully registered it. Its action for rectification of the Register had failed in the Federal Court on the grounds that it was not an “aggrieved person”.

The High Court ruled that Health World was an aggrieved person as it and Shin Sun were trade rivals, selling the health products in question.

They are in the same trade, and they each trade in the class of goods in respect of which the challenged mark is registered.

French CJ, Gummow, Heydon and Bell JJ noted at [22]

the legislative scheme reveals a concern with the condition of the Register of Trade Marks. It is a concern that it have “integrity”[9] and that it be “pure”[10]. It is a “public mischief” if the Register is not pure[11], for there is “public interest in [its] purity”[12]. The concern and the public interest, viewed from the angle of consumers, is to ensure that the Register is maintained as an accurate record of marks which perform their statutory function – to indicate the trade origins of the goods to which it is intended that they be applied[13].

This objective was balanced by a need to stop the courts being clogged by, and trade mark owners being vexed by, busybodies. At [27], their Honours noted:

While the Act offers these facilities for ensuring that the Register is pure in the sense that no mark is to be registered unless valid, and no registration of a mark is to continue if it is not valid, the purpose of ensuring purity exists alongside another purpose. That is the purpose of preventing the security of the Register from being eroded by applications for rectification or removal by busybodies or “common informers or strangers proceeding wantonly”[15] or persons without any interest in the Register or the functions it serves beyond gratifying an intellectual concern or reflecting “merely sentimental motives”[16]. Applications of that kind, by clogging up and causing delay in the courts, would cause an unnecessary cloud to hang over registrations. The purpose of avoiding this outcome is reflected in the standing requirements in ss 88 and 92. Applications by persons who are not aggrieved are positively inimical to the fulfilment of the statutory purposes through the Register.

The Full Federal Court from which the appeal was brought had erred by adopting the rule laid down in Kraft v Gaines, that the exhaustive test for standing included a requirement that trader could, or might reasonably, wish to use the mark under challenge.

Crennan J delivered a concurring opinion. Her Honour differed from the majority in considering that an aggrieved person must be affected by the wrongly registered trade mark. Her Honour accepted that Health World satisfied that test. However, Crennan J considered at [61] “it is not essential to the resolution of these appeals to decide that it is sufficient for “a person aggrieved” to prove no more than trade rivalry with the registrant of the trade mark sought to be removed.”

As a result of this ruling, it would seem that Shin Sun’s trade mark would be removed from the Register on the trial judge‘s findings that Shin Sun did not intend to use or authorise the use of the trade mark (s 59(a)) and Shin Sun had allowed the trade mark to become deceptive or confusing (s 88(2)(c)). Health World second action for removal for non-use under s 92 would also succeed.

Health World Ltd v Shin-Sun Australia Pty Ltd [2010] HCA 13

High Court allows appeal in Health World Read More »

Resale royalty right in the EU

In a dispute over which of Salvador Dali’s heirs is entitled to the benefits of the Community Resale Royalty, the ECJ has ruled that this is a matter for national law.

The 1709 blog has a short report here; IPKat waxes lyrical here.

Case C?518/08, Fundación Gala-Salvador Dalí and Visual Entidad de Gestión de Artistas Plásticos (VEGAP) v Société des auteurs dans les arts graphiques et plastiques (ADAGP)

CAL was recently appointed to administer the absolutely inalienable artist’s resale royalty scheme under the Australian Act, Resale Royalty Right for Visual Artists Act 2009 (Cth), and Minister Garrett has announced that the scheme will come into force on 9 June 2010.

Section 15 of our Act will specify who the heirs can be – the person or person who satisfy “the succession test”:

Succession test
(1)  An entity satisfies the succession test in relation to resale royalty right on the commercial resale of an artistic work, if the entity satisfies:
(a)  criteria 1 and 2 (in subsections (2) and (3)); or
(b)  criteria 3 and 4 (in subsections (4) and (5)).
Criterion 1
(2)  The entity received its interest in the right by testamentary disposition, or in accordance with the rules of intestate succession, on the death of an individual.
Criterion 2
(3)  The entity is one of the following:
(a)  an individual with a beneficial interest in the right;
(b)  a charity or charitable institution with a beneficial interest in the right;
(c)  a community body with a beneficial interest in the right;
(d)  a person who holds an interest in the right in trust for:
(i)  an individual; or
(ii)  a charity or charitable institution; or
(iii)  a community body.
Criterion 3
(4)  The entity received its interest in the right on the winding up of a charity, charitable institution or a community body.
Criterion 4
(5)  The entity is a charity, charitable institution or a community body formed for substantially the same purposes as the body that was wound up.

Resale royalty right in the EU Read More »

Scroll to Top